Clinical Trial Update: Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Benmelstobart in combination with Anlotinib, chemotherapy, and thoracic radiation for limited-stage small cell lung cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart

Snippet

Sponsor: Yayi He | Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 2 | Status: NOT_YET_RECRUITING